Literature DB >> 22069318

Polyubiquitination of transforming growth factor β (TGFβ)-associated kinase 1 mediates nuclear factor-κB activation in response to different inflammatory stimuli.

Anahita Hamidi1, Verena von Bulow, Rosita Hamidi, Nicolas Winssinger, Sofia Barluenga, Carl-Henrik Heldin, Marene Landström.   

Abstract

The transcription factor nuclear factor κB (NF-κB) plays a central role in regulating inflammation in response to several external signals. The TGFβ-associated kinase 1 (TAK1) is an upstream regulator of NF-κB signaling. In TGFβ-stimulated cells, TAK1 undergoes Lys-63-linked polyubiquitination at Lys-34 by TNF receptor-associated factor 6 and is thereby activated. The aim of this study was to investigate whether TAK1 polyubiquitination at Lys-34 is also essential for NF-κB activation via TNF receptor, IL-1 receptor and toll-like receptor 4. We observed that TAK1 polyubiquitination occurred at Lys-34 and required the E3 ubiquitin ligase TNF receptor-associated factor 6 after stimulation of cells with IL-1β. Polyubiquitination of TAK1 also occurred at Lys-34 in cells stimulated by TNF-α and LPS, which activates TLR4, as well as in HepG2 and prostate cancer cells stimulated with TGFβ, which in all cases resulted in NF-κB activation. Expression of a K34R-mutant TAK1 led to a reduced NF-κB activation, IL-6 promoter activity, and proinflammatory cytokine secretion by TNF-α-stimulated PC-3U cells. Similar results were obtained in the mouse macrophage cell line RAW264.7 after LPS treatment. In conclusion, polyubiquitination of TAK1 is correlated with activation of TAK1 and is essential for activation of NF-κB signaling downstream of several receptors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22069318      PMCID: PMC3249064          DOI: 10.1074/jbc.M111.285122

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK.

Authors:  C Wang; L Deng; M Hong; G R Akkaraju; J Inoue ; Z J Chen
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

2.  Autoactivation of transforming growth factor beta-activated kinase 1 is a sequential bimolecular process.

Authors:  Roland Scholz; Corinne L Sidler; Ramon F Thali; Nicolas Winssinger; Peter C F Cheung; Dietbert Neumann
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

Review 3.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

4.  Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.

Authors:  Sofia Edlund; Shizhong Bu; Norbert Schuster; Pontus Aspenström; Rainer Heuchel; Nils-Erik Heldin; Peter ten Dijke; Carl-Henrik Heldin; Maréne Landström
Journal:  Mol Biol Cell       Date:  2003-02       Impact factor: 4.138

5.  Calcineurin activates interleukin-6 transcription in mouse skeletal muscle in vivo and in C2C12 myotubes in vitro.

Authors:  David L Allen; Jill J Uyenishi; Allison S Cleary; Ryan S Mehan; Sarah F Lindsay; Jason M Reed
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-11       Impact factor: 3.619

6.  Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling.

Authors:  Kohsuke Yamazaki; Jin Gohda; Atsuhiro Kanayama; Yusei Miyamoto; Hiroaki Sakurai; Masahiro Yamamoto; Shizuo Akira; Hidetoshi Hayashi; Bing Su; Jun-ichiro Inoue
Journal:  Sci Signal       Date:  2009-10-20       Impact factor: 8.192

7.  Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines.

Authors:  Ping-Hui Tseng; Atsushi Matsuzawa; Weizhou Zhang; Takashi Mino; Dario A A Vignali; Michael Karin
Journal:  Nat Immunol       Date:  2009-11-08       Impact factor: 25.606

8.  Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.

Authors:  Marcello Arsura; Ganesh R Panta; Jennifer D Bilyeu; Lakita G Cavin; Mika A Sovak; Aundrea A Oliver; Valentina Factor; Rainer Heuchel; Frank Mercurio; Snorri S Thorgeirsson; Gail E Sonenshein
Journal:  Oncogene       Date:  2003-01-23       Impact factor: 9.867

9.  A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta.

Authors:  Ming Xu; Brian Skaug; Wenwen Zeng; Zhijian J Chen
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

10.  Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation.

Authors:  Yihui Fan; Yang Yu; Yi Shi; Wenjing Sun; Min Xie; Ningling Ge; Renfang Mao; Alex Chang; Gufeng Xu; Michael D Schneider; Hong Zhang; Songbin Fu; Jun Qin; Jianhua Yang
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

View more
  23 in total

1.  TRAF6 promoted the metastasis of esophageal squamous cell carcinoma.

Authors:  Qingqi Han; Feng Yao; Chenxi Zhong; Heng Zhao
Journal:  Tumour Biol       Date:  2013-09-13

Review 2.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

3.  Effect of TRAF6 on the biological behavior of human lung adenocarcinoma cell.

Authors:  Lou Zhong; Fei Cao; Qingsheng You
Journal:  Tumour Biol       Date:  2012-10-04

4.  Transforming growth factor-β-activated kinase 1 resistance limits glucocorticoid responsiveness to Toll-like receptor 4-mediated inflammation.

Authors:  Fansheng Kong; Gloria Laryea; Zhiwei Liu; Sandip Bhattacharyya
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

Review 5.  Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases.

Authors:  Sabrina Fechtner; David A Fox; Salahuddin Ahmed
Journal:  Rheumatology (Oxford)       Date:  2017-07-01       Impact factor: 7.580

6.  TNF receptor-associated factor 6 regulates proliferation, apoptosis, and invasion of glioma cells.

Authors:  Zhang Peng; Yue Shuangzhu; Jiang Yongjie; Zhang Xinjun; Liu Ying
Journal:  Mol Cell Biochem       Date:  2013-01-29       Impact factor: 3.396

7.  Numblike regulates proliferation, apoptosis, and invasion of lung cancer cell.

Authors:  Li Yingjie; Tang Jian; Yu Changhai; Li Jingbo
Journal:  Tumour Biol       Date:  2013-05-17

8.  The deubiquitinase OTUB1 augments NF-κB-dependent immune responses in dendritic cells in infection and inflammation by stabilizing UBC13.

Authors:  Floriana Mulas; Xu Wang; Shanshan Song; Gopala Nishanth; Wenjing Yi; Anna Brunn; Pia-Katharina Larsen; Berend Isermann; Ulrich Kalinke; Antonio Barragan; Michael Naumann; Martina Deckert; Dirk Schlüter
Journal:  Cell Mol Immunol       Date:  2020-02-05       Impact factor: 11.530

Review 9.  Post-Translational Modifications That Drive Prostate Cancer Progression.

Authors:  Ivana Samaržija
Journal:  Biomolecules       Date:  2021-02-09

10.  Polyubiquitination of Transforming Growth Factor β-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4-mediated JNK and p38 MAPK Activation.

Authors:  I-Ting Chen; Pang-Hung Hsu; Wan-Ching Hsu; Nien-Jung Chen; Ping-Hui Tseng
Journal:  Sci Rep       Date:  2015-07-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.